{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:09:45Z","timestamp":1792080585411,"version":"4.4.0"},"reference-count":37,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"152","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sci. Transl. Med."],"published-print":{"date-parts":[[2012,9,19]]},"abstract":"<jats:p>\n            Administration of a selective GABA\n            <jats:sub>B<\/jats:sub>\n            agonist to individuals with fragile X syndrome improves their deficits in social avoidance, a core symptom of the disease.\n          <\/jats:p>","DOI":"10.1126\/scitranslmed.3004214","type":"journal-article","created":{"date-parts":[[2012,9,19]],"date-time":"2012-09-19T18:16:15Z","timestamp":1348078575000},"source":"Crossref","is-referenced-by-count":253,"title":["Effects of STX209 (Arbaclofen) on Neurobehavioral Function in Children and Adults with Fragile X Syndrome: A Randomized, Controlled, Phase 2 Trial"],"prefix":"10.1126","volume":"4","author":[{"given":"Elizabeth M.","family":"Berry-Kravis","sequence":"first","affiliation":[{"name":"Departments of Pediatrics, Neurological Sciences, and Biochemistry, Rush University Medical Center, Chicago, IL 60612, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hessl","sequence":"additional","affiliation":[{"name":"Medical Investigation of Neurodevelopmental Disorders (MIND) Institute, and Department of Psychiatry and Behavioral Sciences, University of California Davis Medical Center, Sacramento, CA 95817, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Rathmell","sequence":"additional","affiliation":[{"name":"Seaside Therapeutics Inc., Cambridge, MA 02139, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Zarevics","sequence":"additional","affiliation":[{"name":"Seaside Therapeutics Inc., Cambridge, MA 02139, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryann","family":"Cherubini","sequence":"additional","affiliation":[{"name":"Seaside Therapeutics Inc., Cambridge, MA 02139, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Walton-Bowen","sequence":"additional","affiliation":[{"name":"Seaside Therapeutics Inc., Cambridge, MA 02139, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Mu","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Department of Public Health Sciences, University of California, Davis, Sacramento, CA 95817, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danh V.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Department of Public Health Sciences, University of California, Davis, Sacramento, CA 95817, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Gonzalez-Heydrich","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Children\u2019s Hospital Boston, Boston, MA 02115, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul P.","family":"Wang","sequence":"additional","affiliation":[{"name":"Seaside Therapeutics Inc., Cambridge, MA 02139, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall L.","family":"Carpenter","sequence":"additional","affiliation":[{"name":"Seaside Therapeutics Inc., Cambridge, MA 02139, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark F.","family":"Bear","sequence":"additional","affiliation":[{"name":"Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randi J.","family":"Hagerman","sequence":"additional","affiliation":[{"name":"Medical Investigation of Neurodevelopmental Disorders (MIND) Institute, and Department of Pediatrics, University of California Davis Medical Center, Sacramento, CA 95817, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.94.3.577"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa013171"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2010.10.002"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/DBP.0b013e3181ee3833"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nurt.2010.05.005"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-0317"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.31405"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10803-006-0305-9"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(91)90397-H"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2004.04.009"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2007.12.001"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2005.01.038"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2005.06.004"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1002262107"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2008.04.002"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2007.06.003"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1714-10.2010"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.65.11.1315"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11689-010-9067-y"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10803-009-0744-1"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1159\/000329424"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.78"},{"key":"e_1_3_1_24_2","first-page":"4","article-title":"Genetic controls balancing excitatory and inhibitory synaptogenesis in neurodevelopmental disorder models.","volume":"2","author":"Gatto C. L.","year":"2010","unstructured":"Gatto C. L., Broadie K., Genetic controls balancing excitatory and inhibitory synaptogenesis in neurodevelopmental disorder models. Front. Synaptic Neurosci. 2, 4 (2010).","journal-title":"Front. Synaptic Neurosci."},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(01)80053-2"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3004218"},{"key":"e_1_3_1_27_2","unstructured":"E. Mutschler Y. Gietl D. Krauss Stereospecific analysis and human pharmacokinetics of the enantiomers of drugs administered as racemates in Chirality and Biological Activity H. Frank B. Holmstedt B. Testa Eds. (Alan R. Liss New York 1990) p. 283."},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10803-011-1370-2"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-061109-134644"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/mrdd.20007"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3001708"},{"key":"e_1_3_1_32_2","first-page":"485","article-title":"The aberrant behavior checklist: A behavior rating scale for the assessment of treatment effects.","volume":"89","author":"Aman M. G.","year":"1985","unstructured":"Aman M. G., Singh N. N., Stewart A. W., Field C. J., The aberrant behavior checklist: A behavior rating scale for the assessment of treatment effects. Am. J. Ment. Defic. 89, 485\u2013491 (1985).","journal-title":"Am. J. Ment. Defic."},{"key":"e_1_3_1_33_2","doi-asserted-by":"crossref","unstructured":"S. S. Sparrow D. V. Cicchetti D. A. Balla Vineland Adaptive Behavior Scales Second Edition (AGS Publishing Circle Pines 2005).","DOI":"10.1037\/t15164-000"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1025014929212"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10803-006-0213-z"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10802-007-9165-9"},{"key":"e_1_3_1_37_2","doi-asserted-by":"crossref","unstructured":"G. J. DuPaul T. J. Power A. D. Anastopoulos D. Reid ADHD Rating Scale\u2014IV: Checklists Norms and Clinical Interpretations (The Guilford Press New York 1998).","DOI":"10.1037\/t00680-000"},{"key":"e_1_3_1_38_2","doi-asserted-by":"crossref","unstructured":"Owen R. Sikich L. Marcus R. N. Corey-Lisle P. Manos G. McQuade R. D. Carson W. H. Findling R. L. Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics 124 1533\u20131540 (2009).","DOI":"10.1542\/peds.2008-3782"}],"container-title":["Science Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/scitranslmed.3004214","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T17:02:08Z","timestamp":1705424528000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/scitranslmed.3004214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,19]]},"references-count":37,"journal-issue":{"issue":"152","published-print":{"date-parts":[[2012,9,19]]}},"alternative-id":["10.1126\/scitranslmed.3004214"],"URL":"https:\/\/doi.org\/10.1126\/scitranslmed.3004214","relation":{},"ISSN":["1946-6234","1946-6242"],"issn-type":[{"value":"1946-6234","type":"print"},{"value":"1946-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,19]]}}}